Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus- associated gastric carcinoma

Histopathology

Volumn 34, Issue 6, 1999, Pages 502-509

  Kume, T ^a   Oshima, K ^a   Shinohara, T ^a   Takeo, H ^a   Yamashita, Y ^a   Shirakusa, T ^a   Kikuchi, M ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; bcl 2; Epstein Barr virus; Gastric carcinoma

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN BCL X;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; VIRUS CARCINOGENESIS;

ADULT; AGED; APOPTOSIS; CARCINOMA; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 0033022485     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1999.00686.x     Document Type: Article

References (49)

1. 1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; i; 702-703.
2. 2. Magrath IJ, Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin. Cancer Biol. 1992; 3; 285-295.
3. 3. Brousset P, Chittal S, Schlaifer D et al. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAmex) sections. Blood 1991; 77; 1781-1786.
4. 4. Klein G. The relationship of the virus to nasopharyngeal carcinoma. In Epstein MA and Achong BG eds. The Epstein-Barr Virus. Berlin: Springer-Verlag, 1979: 339-350.
5. 5. Pathmanathan R, Prasad U, Chandrika G et al. Undifferentiated, nonkeratinizing and squamous cell carcinoma of the nasopharynx. Am. J. Pathol. 1995; 146; 1355-1367.
6. 6. Burke AP, Yen TS, Shekitka KM et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod. Pathol. 1990; 3; 377-380.
7. 7. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 1992; 140; 769-774.
8. 8. Oda K, Tamura J, Takenouchi T et al. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol. 1993; 143; 1063-1071.
9. 9. Imai S, koizumi S, Sugiura M et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl Acad. Sci. USA 1994; 91; 9131-9135.
10. 10. Fukuyama M, Hayashi Y, Iwasaki Y et al. Epstein-Barr virus associated gastric adenocarcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest. 1994; 71; 73-81.
11. 11. Harn HJ, Chang JY, Wang MW et al. Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum. Pathol. 1995; 26; 267-271.
12. 12. Ohfuji S, Osaki M, Tsujitani S et al. Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma. Int. J. Cancer 1996; 68; 710-715.
13. 13. Japanese Research Society for Gastric Cancer. The General Rules for the Gastric Cancer Study, 12th edn. Tokyo: Kanehara Shuppan, 1993.
14. 14. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26; 239-257.
15. 15. Shibata D, Tokunaga M, Uemura Y et al. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol. 1991; 139; 469-474.
16. 16. Tokunaga M, Uemura Y, Tokudome T et al. Epstein-Barr virus related gastric cancer in Japan: a molecular pathoepidemiological study. Acta Pathol. Jap. 1993; 43; 574-581.
17. 17. Leoncini L, Vindigni C, Megha T et al. Epstein-Barr virus and gastric cancer: data and unanswered questions. Int. J. Cancer 1993; 53; 898-901.
18. 18. Ott G, Kirchner T, Muller-Hermelink HK. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 1994; 25; 323-329.
19. 19. Shousha S, Luqmani YA. Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa. J. Clin. Pathol. 1994; 47; 695-698.
20. 20. Selves J, Bibeau F, Brousset P et al. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathology 1996; 28; 121-127.
21. 21. Tokunaga M, Land CE, Uemura Y et al. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 1993; 143; 1250-1254.
22. 22. Shibata D, Hawes D, Stemmermann GN. Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiol. Biomarkers Prevention 1993; 2; 213-217.
23. 23. Yuen ST, Chung LP, Leung SY et al. In situ detection of Epstein-Barr virus in gastric and colo-rectal adenocarcinomas. Am. J. Pathol. 1994; 18; 1158-1163.
24. 24. Shin WS, Kang MW, Kang JH et al. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans. Am. J. Clin. Pathol. 1996; 105; 174-181.
25. 25. Nakamura S, Ueki T, Yao T et al. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Cancer 1994; 73; 2239-2249.
26. 26. Mori M, Watanabe M, Tanaka S et al. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch. Pathol. Lab. Med. 1994; 118; 990-1001.
27. 27. Wyllie AH. Cell death: a new classification separating apoptosis from necrosis. In Bowen ID and Lockshin RA eds. Cell death in biology and pathology. London: Chapman Hall, 1981: 9-34.
28. 28. Umansky SR. The genetic program of cell death: Hypothesis and some applications: transformation, carcinogenesis, aging. J. Theor. Biol. 1982; 97; 591-602.
29. 29. Brusch W, Kleine L, Tenniswood M. The biochemistry of cell death by apoptosis. Biochem. Cell. Biol. 1990; 68; 1071-1074.
30. 30. Arends MJ, Wyllie AH. Apoptosis: Mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 1991; 32; 223-254.
31. 31. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994; 73; 2013-2026.
32. 32. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 1995; 146; 3-15.
33. 33. Cohen JJ. Apoptosis. Immunol. Today 1993; 14; 126-130.
34. 34. Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis; basic types and mechanisms of cell death. Arch. Pathol. Lab. Med. 1993; 117; 1208-1214.
35. 35. Estman A. Apoptosis: a product of programmed and unprogrammed cell death. Toxicol. Appl. Pharmacol. 1993; 41; 7-12.
36. 36. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 1992; 119; 493-501.
37. 37. Wijsman JH, Jonker RR, Keijzer R et al. A new method to detect apoptosis in paraffin section: in situ end-labeling of fragmented DNA. J. Histochem. Cytochem. 1993; 41; 7-12.
38. 38. Ansari B, Coates PJ, Greenstein BD et al. In situ end-labeling detects DNA strand break in apoptosis and other physiological and pathological states. J. Pathol. 1993; 170; 1-8.
39. 39. Shinohara T, Ohshima K, Murayama H, et al. Apoptosis and proliferation in gastric carcinoma: the association with histological type. Histopathology 1996; 29; 123-129.
40. 40. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemotopietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335; 440-442.
41. 41. Boise LH, Gonzalez-Garcia M, Postema CE et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74; 597-608.
42. 42. Liebowitz D, Kieff E. Epstein-Barr virus. In Roizman B, Whitley RJ and Lopez C eds. The human herpes viruses. New York: Raven Press, 1993; 107-172.
43. 43. Sugimura M, Imai S, Tokunaga M et al. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br. J. Cancer 1996; 74; 625-631.
44. 44. Lee MA, Yates JL. BHRF1 of Epstein-Barr virus, which is hemologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro. J. Virol. 1992; 66; 1899-1906.
45. 45. McCarthy NJ, Hazlewood SA, Huen DS et al. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs. Adv. Exp. Med. Biol. 1996; 406; 83-97.
46. 46. Line D, Shields MT, Ullrich SJ et al. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl Acad. Sci. USA 1992; 89; 9210-9214.
47. 47. Shaw P Bovey R, Tardy S et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl Acad. Sci. USA 1992; 89; 4495-4499.
48. 48. Sakurai S, Sano T, Maeshima A et al. Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality. Virchows Arch. 1995; 427; 119-124.
49. 49. Key G, Becher MHG, Duchrow M et al. New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) prepared against recombinant parts of the Ki-67 antigen. Cell Pathol. 1992; 4; 181.